Get started
Author

Tomiyuki Sugi

Observed name: Sugi, Tomiyuki
ORCID: 0000-0003-1274-6558
Observed ORCID: 0000-0003-1274-6558
OpenAlex ID: A5091311191
Determination of the concentration of gilteritinib in human plasma using HPLC
2020 · Takeo Yasu, Tomiyuki Sugi, et al. · Biomedical Chromatography · 11
Simple desensitization protocol for multiple myeloma patients with lenalidomide‐induced skin rash: Case series
2021 · Tomiyuki Sugi, Mitsuo Mita, et al. · Journal of Clinical Pharmacy and Therapeutics · 7
Analysis of risk factors for lenalidomide-associated skin rash in patients with multiple myeloma
2021 · Tomiyuki Sugi, Yasuo Nishigami, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 7
Increased trough concentration of venetoclax when combined with itraconazole for acute myeloid leukemia
2024 · Masao Hagihara, Takeo Yasu, et al. · Annals of Hematology · 6
Successful Elimination of SARS-CoV-2 Following Vaccination with BNT162b2 after Prolonged Viral Infection in an Immunocompromised Lymphoma Patient
2022 · Masao Hagihara, Yui Imai, et al. · Internal Medicine · 5
PDF
Preceding bortezomib administration for a certain period reduces the risk of lenalidomide‐induced skin rash
2021 · Tomiyuki Sugi, Mitsuo Mita, et al. · Journal of Clinical Pharmacy and Therapeutics · 3
Prevention of pneumocystis pneumonia in patients with hematological diseases: Efficacy of low-dose atovaquone
2023 · Tomiyuki Sugi, Mitsuo Mita, et al. · International Journal of Clinical Pharmacology and Therapeutics · 2
Clinical characteristics and risk factors for pomalidomide-induced skin rash: Implications for pharmacist-led monitoring in real-world multiple myeloma care
2026 · Tomiyuki Sugi, Ryouta Kushi, et al. · Journal of Oncology Pharmacy Practice
Effects of a pharmacist-led GAIN approach on long-acting injectables in schizophrenia
2026 · Masahide Karashima, Makoto Hiraide, et al. · Journal of the American Pharmacists Association
Effects of Pharmacist Intervention on Polypharmacy Avoidance in Psychiatric Hospitals
2025 · Masahide Karashima, Makoto Hiraide, et al. · Annals of Clinical Psychiatry
[Analysis of anti-SARS-CoV-2 IgG antibody titers after mRNA booster vaccination in patients with nonmalignant hematological disorders].
2023 · Masao Hagihara, Tomiyuki Sugi, et al. · PubMed
多発性骨髄腫治療におけるレナリドミドによる皮膚障害のリスク因子解析と脱感作療法
2022 · 杉, 富行, Sugi, Tomiyuki · Institutional Repositories DataBase (IRDB)
PDF
[SARS-CoV2 anti-spike IgG response following COVID-19 mRNA vaccination (BNT162b2) in patients with hematological disorders].
2022 · Masao Hagihara, Tomiyuki Sugi, et al. · PubMed
A Case Report of a Patient with a Hematologic Malignancy Who Was Successfully Switched to Methadone to Treat Opioid-Induced Hyperalgesia by Hydromorphone
2020 · Tomiyuki Sugi, Nishigami Yasuo, et al.
くすりの副作用2017 4 抗がん薬
2017 · Takabatake Keisuke, Tomiyuki Sugi · Dental Diamond
カペシタビンとオキサリプラチン(xelox)に関連した手足症候群に対する保湿剤の効果
2011 · Kazuyoshi Kawakami, Yokokawa Takashi, et al. · 日本臨床腫瘍学会学術集会プログラム・抄録集
Works count: 16
Citation count: 41
H-index: 5
I10-index: 1
Year
Topic
Type